Paolo Doksani

5PUBLICATIONS
34CO-AUTHORS
AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 15, 2026
Complement Inhibition Therapy in Myasthenic Crisis-A Multicentre Retrospective Analysis of 17 Cases From Germany.

Lea Gerischer, Maike Stein, Alice Schneider

|Nov 20, 2025
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab.

Lea Gerischer, Frauke Stascheit, Maximilian Mönch

|Jan 27, 2025
New and Emerging Biological Therapies for Myasthenia Gravis: A Focussed Review for Clinical Decision-Making.

Lea Gerischer, Paolo Doksani, Sarah Hoffmann

|Nov 27, 2024
Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study.

Frauke Stascheit, Carla Daiane Ferreira de Sousa, Annette Aigner

Pageof 1